October 17, 2023
12:00 BST / 13:00 CEST
Online Event
The job of drug hunters is becoming increasingly difficult as previously considered undruggable targets are becoming the norm. Advances in molecular modeling and machine learning are changing the way chemists and biologists approach their drug discovery challenges – in modalities ranging from small molecules to biologics, and from hit discovery through lead optimization.
In this webinar, scientists from Schrödinger will present an overview of our latest technology advances. We will discuss solutions for target enablement, hit discovery, lead optimization, and protein engineering which employ state-of-the-art physics-based methods, machine learning capabilities, and advanced visualization tools. We will show you how these solutions are accessed through Schrödinger’s computational platform using intuitive guided workflows – enabling you to use your expertise and creativity to generate and test new ideas.
Webinar Highlights
Structure Enablement
Virtual Screening
Hit-to-Lead and Lead Optimization
Biologics
Who Should Attend?